From bad to worse: the shortage of fibrinolytics

Eur J Hosp Pharm. 2023 May;30(3):125-126. doi: 10.1136/ejhpharm-2023-003719. Epub 2023 Feb 23.

Lorenz Roger Van der Linden^{1

2}, Jens Neefs³, Thomas Vanassche^{4

5}, Robin Lemmens^{6

7}, Peter Verhamme^{4

5}

¹ Hospital Pharmacy Department, UZ Leuven, Leuven, Flanders, Belgium lorenz.vanderlinden@uzleuven.be.
² Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Flanders, Belgium.
³ Hospital Pharmacy Department, UZ Leuven, Leuven, Flanders, Belgium.
⁴ Department of Cardiovascular Sciences, KU Leuven, Leuven, Flanders, Belgium.
⁵ Department of Cardiology, UZ Leuven, Leuven, Flanders, Belgium.
⁶ Department of Neurosciences, KU Leuven, Leuven, Flanders, Belgium.
⁷ Department of Neurology, UZ Leuven, Leuven, Flanders, Belgium.

No abstract available

Keywords: Organization and Administration; Quality of Health Care; Safety; Thromboembolism.

Publication types